Nancy Chan, MD (@nancychan29) 's Twitter Profile
Nancy Chan, MD

@nancychan29

Breast Medical Oncologist/Director of Breast Cancer Clinical Research/Phase 1 Novel Therapeutics/Mom of princesses:human daughters and golden doodle/yogi

ID: 1494411601444757512

calendar_today17-02-2022 20:41:13

22 Tweet

63 Takipçi

85 Takip Edilen

Perlmutter Cancer Center at NYU Langone Health (@perlmutter_cc) 's Twitter Profile Photo

As the new director of breast cancer clinical research, medical oncologist Dr. Nancy Chan is helping us advance #clinicaltrials for #breastcancer patients. Learn more: bit.ly/3JwZOT6

As the new director of breast cancer clinical research, medical oncologist Dr. Nancy Chan is helping us advance #clinicaltrials for #breastcancer patients. Learn more: bit.ly/3JwZOT6
University of Wisconsin Department of Medicine (@uw_medicine) 's Twitter Profile Photo

We are pleased to announce that Kari Wisinski has been named permanent Chief of UW Hematology-Oncology and Palliative Care! Her vision for the division includes 🏥 improving clinical operations ⬆️ increasing enrollment in interventional clinical trials 🤝 supporting wellness and DEI efforts

We are pleased to announce that <a href="/KariWisinski_MD/">Kari Wisinski</a> has been named permanent Chief of <a href="/uw_hemeoncpc/">UW Hematology-Oncology and Palliative Care</a>! 

Her vision for the division includes
🏥  improving clinical operations
⬆️  increasing enrollment in interventional clinical trials
🤝  supporting wellness and DEI efforts
Perlmutter Cancer Center at NYU Langone Health (@perlmutter_cc) 's Twitter Profile Photo

Medical oncologist Dr. Janice Mehnert Janice Mehnert, MD opened a trial to study safe combination doses and preliminary safety and efficacy for three monoclonal antibody investigational drugs in participants with advanced malignancies. Lean more: bit.ly/3BrVf9V

Medical oncologist Dr. Janice Mehnert <a href="/JaniceM10/">Janice Mehnert, MD</a> opened a trial to study safe combination doses and preliminary safety and efficacy for three monoclonal antibody investigational drugs in participants with advanced malignancies.

Lean more: bit.ly/3BrVf9V
Janice Mehnert, MD (@janicem10) 's Twitter Profile Photo

Delighted that our original work has been accepted for oral presentation in a Clinical Science Symposium entitled “Aspirations of Equity in Oncology” at ASCO. Will post details as the meeting gets closer. Best part was many great collaborators. Pamela Kunz, MD, FASCO Kristen Spencer

Kari Wisinski (@kariwisinski_md) 's Twitter Profile Photo

A thanks to Ticiana Batista (Leal) Nancy Chan, MD Marina Sharifi and all the pts. Carbo/taxol + talazoparib is feasible but with cytopenias. A phase I study of talazoparib with carboplatin/ paclitaxel in advanced solid tumors (NCI9782) onlinelibrary.wiley.com/doi/full/10.10…

Janice Mehnert, MD (@janicem10) 's Twitter Profile Photo

I've been part of ASCO for years, but our work has never been a major part of a Clinical Science Symposium. This project is very important to me as it is our first publication in gender equity research. It also allowed me to bring together colleagues old and new.

I've been part of <a href="/ASCO/">ASCO</a> for years, but our work has never been a major part of a Clinical Science Symposium. This project is very important to me as it is our first publication in gender equity research. It also allowed me to bring together colleagues old and new.
Janice Mehnert, MD (@janicem10) 's Twitter Profile Photo

Our chief fellow Jess Caro from Perlmutter Cancer Center at NYU Langone Health will take it away 9:48 am 6/6 in E350, but come at 9 for the whole session."Aspirations of Equity In Oncology" chaired by Fumiko Ladd Chino, MD, FASCO and Jaydira Del Rivero. It's about about creating opportunities for equity at the end of the day.

Coral Omene, MD, PhD (@omene_co) 's Twitter Profile Photo

I am grateful to the V Foundation for this award. I look forward to contributing to the Mission of the Foundation in this important endeavor to increase Clinical Trial participation of Black women with Breast Cancer.Rutgers Cancer Institute The V Foundation